DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook
DexCom Inc. (NASDAQ:DXCM) is one of the best medical technology stocks to invest in. On February 12, DexCom Inc.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 3,938,568 | $261,402,758 | +79% | 0.14% |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 2,527,448 | $167,746,724 | +133% | 0.18% |
| 3. | Castle Hook Partners Josh Donfeld And David Rogers | 2,251,011 | $149,399,600 | +273% | 0.62% |
| 4. | Millennium Management Israel Englander | 1,589,877 | $105,520,136 | -54% | 0.04% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 1,587,550 | $105,365,694 | +667% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.43 | 2,500 | $138,563.00 | 331,697 | 2025-11-10 | Filing | |
| $54.98 | 15,700 | $863,138.90 | 329,197 | 2025-11-10 | Filing | |
| $50.01 | 25,000 | $1,250,250.00 | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | $496,100.00 | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | $1,085,000.00 | 121,975 | 2013-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $68.01 | 1,012 | $68,826.12 | 26,019 | 2026-02-12 | Filing | |
| $59.05 | 2,906 | $171,599.30 | 35,088 | 2025-11-14 | Filing | |
| $58.07 | 1,012 | $58,766.84 | 27,031 | 2025-11-12 | Filing | |
| $55.17 | 3,948 | $217,811.16 | 37,994 | 2025-11-10 | Filing | |
| $80.86 | 667 | $53,933.62 | 22,667 | 2025-09-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 49,074,378 | $3,257,066,468 | 0.05% | |
| 2. | 39,848,377 | $2,644,736,811 | 0.04% | |
| 3. | 18,093,554 | $1,200,869,179 | 0.04% | |
| 4. | 15,552,587 | $1,032,225,198 | 0.86% | |
| 5. | 11,006,183 | $727,841,809 | 0.04% |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
DexCom, Inc. (NASDAQ:DXCM) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, good afternoon, welcome to the DexCom, Inc. Fourth Quarter and Fiscal Year 2025 Earnings Release Conference Call. My name is Abby, I will be your operator today.
Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive
As of the January 28 closing, DexCom Inc. (NASDAQ:DXCM) had highly bullish sentiment according to consensus. Out of 22 analysts who covered the stock, 18 assigned Buy ratings and 3 gave Hold calls.
12 Best Medical Devices Stocks to Invest In According to Hedge Funds
It is challenging to identify segments within the markets that appear to be defensive plays, yet offer innovation potential.
12 Best US Stocks to Buy and Hold in 2026
On January 17, Ryan Detrick of Carson Group joined CNBC's 'Closing Bell Overtime' to talk about why he thinks the bull market still has room to run.
DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025
DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts.
13 Best Fundamental Stocks to Buy According to Analysts
Goldman Sachs Research anticipates that the US stocks will post a fourth-straight year of gains in 2026.
Morgan Stanley Upgrades DexCom (DXCM), Cites Undervalued Recovery and G7 Margin Potential
DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026.
10 Best Growth Stocks to Buy in 2026
On December 10, Meghan Shue, Wilmington Trust chief investment strategist, appeared on CNBC's 'The Exchange'.
Hedge Fund Resource Center Billionaire Hedge Funds
